China Inherited Ventricular Arrhythmias Registry - Trial NCT03880708
Access comprehensive clinical trial information for NCT03880708 through Pure Global AI's free database. This phase not specified trial is sponsored by China National Center for Cardiovascular Diseases and is currently Recruiting. The study focuses on Ventricular Arrythmia. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
China National Center for Cardiovascular Diseases
Timeline & Enrollment
N/A
Oct 24, 2017
Oct 24, 2027
Primary Outcome
sustained tachycardia/ ventricular fibrillation or sudden cardiac death
Summary
This is an observational, prospective, multi-center registry, aiming at building a risk
 stratification for malignant inherited ventricular arrhythmias, including Brugada
 syndrome(Brs)ใLong QT syndrome(LQTS)ใShort QT syndrome(SQTS)ใEarly repolarization
 syndrome(ERS) and Catecholaminergic polymorphic ventricular tachycardia(CPVT). 500
 participants will be recruited from 10 centers in China, with clinical data to be abstracted
 from medical records, and blood samples to be collected for finding related genes and
 promising risk indicators. The follow-up should be made every 6 months.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT03880708
Non-Device Trial